Highlights
In a study published this week at the BMC Genomics journal researchers of the Division of Molecular Biology and Genetics and the FLEMING's Genomics F …
Read more
International recognition of a molecular biology database developed in Greece. Diana-TarBase, the database of experimentally verified microRNA targets …
Read more
This year's Carol Nachman Prize for Rheumatology was awarded to BSRC Fleming researcher, biologist Prof. Dr. George Kollias. The Prize is one of Ger …
Read more
The quality of the work performed at the Fleming Genomics Facility has recently been recognized in the Run RecognitION League of the Ion Community.
…
Read more
600 graduate students and postdoctoral scientists are selected worldwide after nomination from scientists of their home countries to attend the yearly …
Read more
FLEMING joins Infrafrontier GmbH. The Center is now a Founding Member of Infrafrontier GmbH, the managing entity of the European ESFRI Infrafrastructu …
Read more
Fleming researcher Iannis Talianidis has been elected member of Academia Europaea. Earlier this year he was elected Foreign Member of the Hungarian Ac …
Read more
Novel osteoporosis models. In a study published this week at the Journal of Bone and Mineral Research (DOI: 10.1002/jbmr.2112) the research group of E …
Read more
Fleming researcher Prof. George Kollias has been awarded an Advanced ERC grant, to tackle the role of mesenchymal cells (MC) in intestinal homeostasis …
Read more
Fighting cancer: FAK levels do matter. In a study published today at Nature Communication (DOI: 10.1038/ncomms3020), Fleming researcher Vassiliki Kost …
Read more
Tumor necrosis by TNF revisited: In a study published today at JCI, Fleming researchers, in collaboration with Ghent University, VIB and Biomedcode He …
Read more
In recognition of eminent scientific discoveries and contributions to science, Fleming researcher Professor George Kollias was elected March 14th 2013 …
Read more
A new study published in PLoSOne by the Turin and Skoulakis labs in collaboration with the local fragrance chemistry company Vioryl demontrates that h …
Read more
In the context of Fleming's strategic plans for the creation of a "Biotechnopolis" in its premises, the Center participates in ESFRI Infrastructure IN …
Read more
Fleming researchers have uncovered novel cancer modulating pathways acting in the mesenchymal microenvironment of colon tumors. …
Read more
In a paper marked as “must read” from the Journal of Neuroscience, the Skoulakis lab revealed a novel regulatory loop connecting metabotropic Glut …
Read more
Fleming researcher receives ERC Starting/Consolidator Grant. Dr Maria Fousteri was awarded the prestigious ERC Starting/Consolidator Grant to study ep …
Read more
Fleming researchers have revealed a major role for Autotaxin (ATX, ENPP2) and its bioactive lipid product lysophosphatidic acid (LPA) in the pathogene …
Read more
Using miRNA profiling in synovial fibroblasts from an animal model of rheumatoid arthritis, Fleming researchers were able to predict novel miRNAs asso …
Read more
Using the EAE mouse model of Multiple Sclerosis (MS), Fleming researchers have uncovered the cellular basis of a pathologically significant role for T …
Read more
Fleming Researchers (Kontoyiannis Group) revealed the importance of the mRNA regulator HuR, in inflammation supporting tumor development.
…
Read more
Fleming researcher receives ERC Advanced Grant. Iannis Talianidis (Director of IMBG) was awarded the prestigious ERC Advanced Investigator Grant to st …
Read more
Fleming’s researchers have discovered a functional mutation in the mouse Rankl gene that causes Autosomal Recessive Osteopetrosis, a lethal inherite …
Read more
Research in the Skoulakis lab identified the Receptor Tyrosine kinase Alk as essential for for manifestation of neurofibromatosis1, a common (1 in 350 …
Read more